sch 28080 has been researched along with arginine vasopressin in 1 studies
Studies (sch 28080) | Trials (sch 28080) | Recent Studies (post-2010) (sch 28080) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
---|---|---|---|---|---|
217 | 0 | 20 | 12,278 | 422 | 1,212 |
Protein | Taxonomy | sch 28080 (IC50) | arginine vasopressin (IC50) |
---|---|---|---|
Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attmane-Elakeb, A; Bichara, M; Boulanger, H; Vernimmen, C | 1 |
1 other study(ies) available for sch 28080 and arginine vasopressin
Article | Year |
---|---|
Apical location and inhibition by arginine vasopressin of K+/H+ antiport of the medullary thick ascending limb of rat kidney.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Triphosphatases; Amiloride; Animals; Antiporters; Arginine Vasopressin; Barium; Calcium Channel Blockers; Cyclic AMP-Dependent Protein Kinases; Diuretics; Enzyme Inhibitors; Hydrogen; Hydrogen-Ion Concentration; Imidazoles; Loop of Henle; Male; Potassium Channels; Potassium-Hydrogen Antiporters; Rats; Rats, Sprague-Dawley; Renal Agents; Rubidium; Verapamil | 1997 |